Global Liposomal Formulation Development Service Market Insights, Forecast to 2030

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Liposomal Formulation Development Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Small Molecules
        1.2.3 Proteins
        1.2.4 Peptides
        1.2.5 Nucleic Acids
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Liposomal Formulation Development Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Research
        1.3.3 Clinical
        1.3.4 Commercial
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Liposomal Formulation Development Service Market Perspective (2019-2030)
    2.2 Global Liposomal Formulation Development Service Growth Trends by Region
        2.2.1 Liposomal Formulation Development Service Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Liposomal Formulation Development Service Historic Market Size by Region (2019-2024)
        2.2.3 Liposomal Formulation Development Service Forecasted Market Size by Region (2025-2030)
    2.3 Liposomal Formulation Development Service Market Dynamics
        2.3.1 Liposomal Formulation Development Service Industry Trends
        2.3.2 Liposomal Formulation Development Service Market Drivers
        2.3.3 Liposomal Formulation Development Service Market Challenges
        2.3.4 Liposomal Formulation Development Service Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Revenue Liposomal Formulation Development Service by Players
        3.1.1 Global Liposomal Formulation Development Service Revenue by Players (2019-2024)
        3.1.2 Global Liposomal Formulation Development Service Revenue Market Share by Players (2019-2024)
    3.2 Global Liposomal Formulation Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Liposomal Formulation Development Service, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Liposomal Formulation Development Service Market Concentration Ratio
        3.4.1 Global Liposomal Formulation Development Service Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Liposomal Formulation Development Service Revenue in 2023
    3.5 Global Key Players of Liposomal Formulation Development Service Head office and Area Served
    3.6 Global Key Players of Liposomal Formulation Development Service, Product and Application
    3.7 Global Key Players of Liposomal Formulation Development Service, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Liposomal Formulation Development Service Breakdown Data by Type
    4.1 Global Liposomal Formulation Development Service Historic Market Size by Type (2019-2024)
    4.2 Global Liposomal Formulation Development Service Forecasted Market Size by Type (2025-2030)

5 Liposomal Formulation Development Service Breakdown Data by Application
    5.1 Global Liposomal Formulation Development Service Historic Market Size by Application (2019-2024)
    5.2 Global Liposomal Formulation Development Service Forecasted Market Size by Application (2025-2030)

6 North America
    6.1 North America Liposomal Formulation Development Service Market Size (2019-2030)
    6.2 North America Liposomal Formulation Development Service Market Size by Type
        6.2.1 North America Liposomal Formulation Development Service Market Size by Type (2019-2024)
        6.2.2 North America Liposomal Formulation Development Service Market Size by Type (2025-2030)
        6.2.3 North America Liposomal Formulation Development Service Market Share by Type (2019-2030)
    6.3 North America Liposomal Formulation Development Service Market Size by Application
        6.3.1 North America Liposomal Formulation Development Service Market Size by Application (2019-2024)
        6.3.2 North America Liposomal Formulation Development Service Market Size by Application (2025-2030)
        6.3.3 North America Liposomal Formulation Development Service Market Share by Application (2019-2030)
    6.4 North America Liposomal Formulation Development Service Market Size by Country
        6.4.1 North America Liposomal Formulation Development Service Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Liposomal Formulation Development Service Market Size by Country (2019-2024)
        6.4.3 North America Liposomal Formulation Development Service Market Size by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

7 Europe
    7.1 Europe Liposomal Formulation Development Service Market Size (2019-2030)
    7.2 Europe Liposomal Formulation Development Service Market Size by Type
        7.2.1 Europe Liposomal Formulation Development Service Market Size by Type (2019-2024)
        7.2.2 Europe Liposomal Formulation Development Service Market Size by Type (2025-2030)
        7.2.3 Europe Liposomal Formulation Development Service Market Share by Type (2019-2030)
    7.3 Europe Liposomal Formulation Development Service Market Size by Application
        7.3.1 Europe Liposomal Formulation Development Service Market Size by Application (2019-2024)
        7.3.2 Europe Liposomal Formulation Development Service Market Size by Application (2025-2030)
        7.3.3 Europe Liposomal Formulation Development Service Market Share by Application (2019-2030)
    7.4 Europe Liposomal Formulation Development Service Market Size by Country
        7.4.1 Europe Liposomal Formulation Development Service Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Liposomal Formulation Development Service Market Size by Country (2019-2024)
        7.4.3 Europe Liposomal Formulation Development Service Market Size by Country (2025-2030)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

8 China
    8.1 China Liposomal Formulation Development Service Market Size (2019-2030)
    8.2 China Liposomal Formulation Development Service Market Size by Type
        8.2.1 China Liposomal Formulation Development Service Market Size by Type (2019-2024)
        8.2.2 China Liposomal Formulation Development Service Market Size by Type (2025-2030)
        8.2.3 China Liposomal Formulation Development Service Market Share by Type (2019-2030)
    8.3 China Liposomal Formulation Development Service Market Size by Application
        8.3.1 China Liposomal Formulation Development Service Market Size by Application (2019-2024)
        8.3.2 China Liposomal Formulation Development Service Market Size by Application (2025-2030)
        8.3.3 China Liposomal Formulation Development Service Market Share by Application (2019-2030)

9 Asia (excluding China)
    9.1 Asia Liposomal Formulation Development Service Market Size (2019-2030)
    9.2 Asia Liposomal Formulation Development Service Market Size by Type
        9.2.1 Asia Liposomal Formulation Development Service Market Size by Type (2019-2024)
        9.2.2 Asia Liposomal Formulation Development Service Market Size by Type (2025-2030)
        9.2.3 Asia Liposomal Formulation Development Service Market Share by Type (2019-2030)
    9.3 Asia Liposomal Formulation Development Service Market Size by Application
        9.3.1 Asia Liposomal Formulation Development Service Market Size by Application (2019-2024)
        9.3.2 Asia Liposomal Formulation Development Service Market Size by Application (2025-2030)
        9.3.3 Asia Liposomal Formulation Development Service Market Share by Application (2019-2030)
    9.4 Asia Liposomal Formulation Development Service Market Size by Region
        9.4.1 Asia Liposomal Formulation Development Service Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Liposomal Formulation Development Service Market Size by Region (2019-2024)
        9.4.3 Asia Liposomal Formulation Development Service Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

11 Key Players Profiles
    11.1 Creative Biolabs
        11.1.1 Creative Biolabs Company Details
        11.1.2 Creative Biolabs Business Overview
        11.1.3 Creative Biolabs Liposomal Formulation Development Service Introduction
        11.1.4 Creative Biolabs Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.1.5 Creative Biolabs Recent Developments
    11.2 LipExoGen
        11.2.1 LipExoGen Company Details
        11.2.2 LipExoGen Business Overview
        11.2.3 LipExoGen Liposomal Formulation Development Service Introduction
        11.2.4 LipExoGen Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.2.5 LipExoGen Recent Developments
    11.3 Project Pharmaceutics
        11.3.1 Project Pharmaceutics Company Details
        11.3.2 Project Pharmaceutics Business Overview
        11.3.3 Project Pharmaceutics Liposomal Formulation Development Service Introduction
        11.3.4 Project Pharmaceutics Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.3.5 Project Pharmaceutics Recent Developments
    11.4 Polymun
        11.4.1 Polymun Company Details
        11.4.2 Polymun Business Overview
        11.4.3 Polymun Liposomal Formulation Development Service Introduction
        11.4.4 Polymun Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.4.5 Polymun Recent Developments
    11.5 Exelead
        11.5.1 Exelead Company Details
        11.5.2 Exelead Business Overview
        11.5.3 Exelead Liposomal Formulation Development Service Introduction
        11.5.4 Exelead Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.5.5 Exelead Recent Developments
    11.6 CD Formulation
        11.6.1 CD Formulation Company Details
        11.6.2 CD Formulation Business Overview
        11.6.3 CD Formulation Liposomal Formulation Development Service Introduction
        11.6.4 CD Formulation Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.6.5 CD Formulation Recent Developments
    11.7 Anglo Bio-Pharma Limited
        11.7.1 Anglo Bio-Pharma Limited Company Details
        11.7.2 Anglo Bio-Pharma Limited Business Overview
        11.7.3 Anglo Bio-Pharma Limited Liposomal Formulation Development Service Introduction
        11.7.4 Anglo Bio-Pharma Limited Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.7.5 Anglo Bio-Pharma Limited Recent Developments
    11.8 Liposoma BV
        11.8.1 Liposoma BV Company Details
        11.8.2 Liposoma BV Business Overview
        11.8.3 Liposoma BV Liposomal Formulation Development Service Introduction
        11.8.4 Liposoma BV Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.8.5 Liposoma BV Recent Developments
    11.9 Dalton Pharma Services
        11.9.1 Dalton Pharma Services Company Details
        11.9.2 Dalton Pharma Services Business Overview
        11.9.3 Dalton Pharma Services Liposomal Formulation Development Service Introduction
        11.9.4 Dalton Pharma Services Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.9.5 Dalton Pharma Services Recent Developments
    11.10 Creative Biostructure
        11.10.1 Creative Biostructure Company Details
        11.10.2 Creative Biostructure Business Overview
        11.10.3 Creative Biostructure Liposomal Formulation Development Service Introduction
        11.10.4 Creative Biostructure Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.10.5 Creative Biostructure Recent Developments
    11.11 BOC Sciences
        11.11.1 BOC Sciences Company Details
        11.11.2 BOC Sciences Business Overview
        11.11.3 BOC Sciences Liposomal Formulation Development Service Introduction
        11.11.4 BOC Sciences Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.11.5 BOC Sciences Recent Developments
    11.12 Encapsula NanoSciences LLC
        11.12.1 Encapsula NanoSciences LLC Company Details
        11.12.2 Encapsula NanoSciences LLC Business Overview
        11.12.3 Encapsula NanoSciences LLC Liposomal Formulation Development Service Introduction
        11.12.4 Encapsula NanoSciences LLC Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.12.5 Encapsula NanoSciences LLC Recent Developments
    11.13 Fujifilm
        11.13.1 Fujifilm Company Details
        11.13.2 Fujifilm Business Overview
        11.13.3 Fujifilm Liposomal Formulation Development Service Introduction
        11.13.4 Fujifilm Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.13.5 Fujifilm Recent Developments
    11.14 CD Bioparticles
        11.14.1 CD Bioparticles Company Details
        11.14.2 CD Bioparticles Business Overview
        11.14.3 CD Bioparticles Liposomal Formulation Development Service Introduction
        11.14.4 CD Bioparticles Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.14.5 CD Bioparticles Recent Developments
    11.15 Precision NanoSystems
        11.15.1 Precision NanoSystems Company Details
        11.15.2 Precision NanoSystems Business Overview
        11.15.3 Precision NanoSystems Liposomal Formulation Development Service Introduction
        11.15.4 Precision NanoSystems Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.15.5 Precision NanoSystems Recent Developments
    11.16 Evonik
        11.16.1 Evonik Company Details
        11.16.2 Evonik Business Overview
        11.16.3 Evonik Liposomal Formulation Development Service Introduction
        11.16.4 Evonik Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.16.5 Evonik Recent Developments
    11.17 Genevant Sciences
        11.17.1 Genevant Sciences Company Details
        11.17.2 Genevant Sciences Business Overview
        11.17.3 Genevant Sciences Liposomal Formulation Development Service Introduction
        11.17.4 Genevant Sciences Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.17.5 Genevant Sciences Recent Developments
    11.18 Avanti Polar Lipids
        11.18.1 Avanti Polar Lipids Company Details
        11.18.2 Avanti Polar Lipids Business Overview
        11.18.3 Avanti Polar Lipids Liposomal Formulation Development Service Introduction
        11.18.4 Avanti Polar Lipids Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.18.5 Avanti Polar Lipids Recent Developments
    11.19 Nippon Fine Chemical
        11.19.1 Nippon Fine Chemical Company Details
        11.19.2 Nippon Fine Chemical Business Overview
        11.19.3 Nippon Fine Chemical Liposomal Formulation Development Service Introduction
        11.19.4 Nippon Fine Chemical Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.19.5 Nippon Fine Chemical Recent Developments
    11.20 Lipoid
        11.20.1 Lipoid Company Details
        11.20.2 Lipoid Business Overview
        11.20.3 Lipoid Liposomal Formulation Development Service Introduction
        11.20.4 Lipoid Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.20.5 Lipoid Recent Developments
    11.21 Corden Pharma
        11.21.1 Corden Pharma Company Details
        11.21.2 Corden Pharma Business Overview
        11.21.3 Corden Pharma Liposomal Formulation Development Service Introduction
        11.21.4 Corden Pharma Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.21.5 Corden Pharma Recent Developments
    11.22 Acuitas Therapeutics
        11.22.1 Acuitas Therapeutics Company Details
        11.22.2 Acuitas Therapeutics Business Overview
        11.22.3 Acuitas Therapeutics Liposomal Formulation Development Service Introduction
        11.22.4 Acuitas Therapeutics Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.22.5 Acuitas Therapeutics Recent Developments
    11.23 T&T Scientific
        11.23.1 T&T Scientific Company Details
        11.23.2 T&T Scientific Business Overview
        11.23.3 T&T Scientific Liposomal Formulation Development Service Introduction
        11.23.4 T&T Scientific Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.23.5 T&T Scientific Recent Developments
    11.24 FormuMax Scientific
        11.24.1 FormuMax Scientific Company Details
        11.24.2 FormuMax Scientific Business Overview
        11.24.3 FormuMax Scientific Liposomal Formulation Development Service Introduction
        11.24.4 FormuMax Scientific Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.24.5 FormuMax Scientific Recent Developments
    11.25 PlantaCorp
        11.25.1 PlantaCorp Company Details
        11.25.2 PlantaCorp Business Overview
        11.25.3 PlantaCorp Liposomal Formulation Development Service Introduction
        11.25.4 PlantaCorp Revenue in Liposomal Formulation Development Service Business (2019-2024)
        11.25.5 PlantaCorp Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Liposomal Formulation Development Service Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Small Molecules
    Table 3. Key Players of Proteins
    Table 4. Key Players of Peptides
    Table 5. Key Players of Nucleic Acids
    Table 6. Key Players of Others
    Table 7. Global Liposomal Formulation Development Service Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Liposomal Formulation Development Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Liposomal Formulation Development Service Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Liposomal Formulation Development Service Market Share by Region (2019-2024)
    Table 11. Global Liposomal Formulation Development Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Liposomal Formulation Development Service Market Share by Region (2025-2030)
    Table 13. Liposomal Formulation Development Service Market Trends
    Table 14. Liposomal Formulation Development Service Market Drivers
    Table 15. Liposomal Formulation Development Service Market Challenges
    Table 16. Liposomal Formulation Development Service Market Restraints
    Table 17. Global Liposomal Formulation Development Service Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Liposomal Formulation Development Service Revenue Share by Players (2019-2024)
    Table 19. Global Top Liposomal Formulation Development Service by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Formulation Development Service as of 2023)
    Table 20. Global Liposomal Formulation Development Service Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Liposomal Formulation Development Service Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Liposomal Formulation Development Service, Headquarters and Area Served
    Table 23. Global Key Players of Liposomal Formulation Development Service, Product and Application
    Table 24. Global Key Players of Liposomal Formulation Development Service, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Liposomal Formulation Development Service Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Liposomal Formulation Development Service Revenue Market Share by Type (2019-2024)
    Table 28. Global Liposomal Formulation Development Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Liposomal Formulation Development Service Revenue Market Share by Type (2025-2030)
    Table 30. Global Liposomal Formulation Development Service Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Liposomal Formulation Development Service Revenue Share by Application (2019-2024)
    Table 32. Global Liposomal Formulation Development Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Liposomal Formulation Development Service Revenue Share by Application (2025-2030)
    Table 34. North America Liposomal Formulation Development Service Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Liposomal Formulation Development Service Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Liposomal Formulation Development Service Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Liposomal Formulation Development Service Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Liposomal Formulation Development Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Liposomal Formulation Development Service Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Liposomal Formulation Development Service Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Liposomal Formulation Development Service Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Liposomal Formulation Development Service Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Liposomal Formulation Development Service Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Liposomal Formulation Development Service Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Liposomal Formulation Development Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Liposomal Formulation Development Service Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Liposomal Formulation Development Service Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Liposomal Formulation Development Service Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Liposomal Formulation Development Service Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Liposomal Formulation Development Service Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Liposomal Formulation Development Service Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Liposomal Formulation Development Service Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Liposomal Formulation Development Service Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Liposomal Formulation Development Service Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Liposomal Formulation Development Service Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Liposomal Formulation Development Service Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Liposomal Formulation Development Service Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Liposomal Formulation Development Service Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Liposomal Formulation Development Service Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Creative Biolabs Company Details
    Table 67. Creative Biolabs Business Overview
    Table 68. Creative Biolabs Liposomal Formulation Development Service Product
    Table 69. Creative Biolabs Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 70. Creative Biolabs Recent Developments
    Table 71. LipExoGen Company Details
    Table 72. LipExoGen Business Overview
    Table 73. LipExoGen Liposomal Formulation Development Service Product
    Table 74. LipExoGen Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 75. LipExoGen Recent Developments
    Table 76. Project Pharmaceutics Company Details
    Table 77. Project Pharmaceutics Business Overview
    Table 78. Project Pharmaceutics Liposomal Formulation Development Service Product
    Table 79. Project Pharmaceutics Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 80. Project Pharmaceutics Recent Developments
    Table 81. Polymun Company Details
    Table 82. Polymun Business Overview
    Table 83. Polymun Liposomal Formulation Development Service Product
    Table 84. Polymun Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 85. Polymun Recent Developments
    Table 86. Exelead Company Details
    Table 87. Exelead Business Overview
    Table 88. Exelead Liposomal Formulation Development Service Product
    Table 89. Exelead Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 90. Exelead Recent Developments
    Table 91. CD Formulation Company Details
    Table 92. CD Formulation Business Overview
    Table 93. CD Formulation Liposomal Formulation Development Service Product
    Table 94. CD Formulation Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 95. CD Formulation Recent Developments
    Table 96. Anglo Bio-Pharma Limited Company Details
    Table 97. Anglo Bio-Pharma Limited Business Overview
    Table 98. Anglo Bio-Pharma Limited Liposomal Formulation Development Service Product
    Table 99. Anglo Bio-Pharma Limited Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 100. Anglo Bio-Pharma Limited Recent Developments
    Table 101. Liposoma BV Company Details
    Table 102. Liposoma BV Business Overview
    Table 103. Liposoma BV Liposomal Formulation Development Service Product
    Table 104. Liposoma BV Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 105. Liposoma BV Recent Developments
    Table 106. Dalton Pharma Services Company Details
    Table 107. Dalton Pharma Services Business Overview
    Table 108. Dalton Pharma Services Liposomal Formulation Development Service Product
    Table 109. Dalton Pharma Services Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 110. Dalton Pharma Services Recent Developments
    Table 111. Creative Biostructure Company Details
    Table 112. Creative Biostructure Business Overview
    Table 113. Creative Biostructure Liposomal Formulation Development Service Product
    Table 114. Creative Biostructure Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 115. Creative Biostructure Recent Developments
    Table 116. BOC Sciences Company Details
    Table 117. BOC Sciences Business Overview
    Table 118. BOC Sciences Liposomal Formulation Development Service Product
    Table 119. BOC Sciences Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 120. BOC Sciences Recent Developments
    Table 121. Encapsula NanoSciences LLC Company Details
    Table 122. Encapsula NanoSciences LLC Business Overview
    Table 123. Encapsula NanoSciences LLC Liposomal Formulation Development Service Product
    Table 124. Encapsula NanoSciences LLC Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 125. Encapsula NanoSciences LLC Recent Developments
    Table 126. Fujifilm Company Details
    Table 127. Fujifilm Business Overview
    Table 128. Fujifilm Liposomal Formulation Development Service Product
    Table 129. Fujifilm Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 130. Fujifilm Recent Developments
    Table 131. CD Bioparticles Company Details
    Table 132. CD Bioparticles Business Overview
    Table 133. CD Bioparticles Liposomal Formulation Development Service Product
    Table 134. CD Bioparticles Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 135. CD Bioparticles Recent Developments
    Table 136. Precision NanoSystems Company Details
    Table 137. Precision NanoSystems Business Overview
    Table 138. Precision NanoSystems Liposomal Formulation Development Service Product
    Table 139. Precision NanoSystems Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 140. Precision NanoSystems Recent Developments
    Table 141. Evonik Company Details
    Table 142. Evonik Business Overview
    Table 143. Evonik Liposomal Formulation Development Service Product
    Table 144. Evonik Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 145. Evonik Recent Developments
    Table 146. Genevant Sciences Company Details
    Table 147. Genevant Sciences Business Overview
    Table 148. Genevant Sciences Liposomal Formulation Development Service Product
    Table 149. Genevant Sciences Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 150. Genevant Sciences Recent Developments
    Table 151. Avanti Polar Lipids Company Details
    Table 152. Avanti Polar Lipids Business Overview
    Table 153. Avanti Polar Lipids Liposomal Formulation Development Service Product
    Table 154. Avanti Polar Lipids Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 155. Avanti Polar Lipids Recent Developments
    Table 156. Nippon Fine Chemical Company Details
    Table 157. Nippon Fine Chemical Business Overview
    Table 158. Nippon Fine Chemical Liposomal Formulation Development Service Product
    Table 159. Nippon Fine Chemical Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 160. Nippon Fine Chemical Recent Developments
    Table 161. Lipoid Company Details
    Table 162. Lipoid Business Overview
    Table 163. Lipoid Liposomal Formulation Development Service Product
    Table 164. Lipoid Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 165. Lipoid Recent Developments
    Table 166. Corden Pharma Company Details
    Table 167. Corden Pharma Business Overview
    Table 168. Corden Pharma Liposomal Formulation Development Service Product
    Table 169. Corden Pharma Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 170. Corden Pharma Recent Developments
    Table 171. Acuitas Therapeutics Company Details
    Table 172. Acuitas Therapeutics Business Overview
    Table 173. Acuitas Therapeutics Liposomal Formulation Development Service Product
    Table 174. Acuitas Therapeutics Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 175. Acuitas Therapeutics Recent Developments
    Table 176. T&T Scientific Company Details
    Table 177. T&T Scientific Business Overview
    Table 178. T&T Scientific Liposomal Formulation Development Service Product
    Table 179. T&T Scientific Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 180. T&T Scientific Recent Developments
    Table 181. FormuMax Scientific Company Details
    Table 182. FormuMax Scientific Business Overview
    Table 183. FormuMax Scientific Liposomal Formulation Development Service Product
    Table 184. FormuMax Scientific Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 185. FormuMax Scientific Recent Developments
    Table 186. PlantaCorp Company Details
    Table 187. PlantaCorp Business Overview
    Table 188. PlantaCorp Liposomal Formulation Development Service Product
    Table 189. PlantaCorp Revenue in Liposomal Formulation Development Service Business (2019-2024) & (US$ Million)
    Table 190. PlantaCorp Recent Developments
    Table 191. Research Programs/Design for This Report
    Table 192. Key Data Information from Secondary Sources
    Table 193. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Liposomal Formulation Development Service Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Liposomal Formulation Development Service Market Share by Type: 2023 VS 2030
    Figure 3. Small Molecules Features
    Figure 4. Proteins Features
    Figure 5. Peptides Features
    Figure 6. Nucleic Acids Features
    Figure 7. Others Features
    Figure 8. Global Liposomal Formulation Development Service Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Liposomal Formulation Development Service Market Share by Application: 2023 VS 2030
    Figure 10. Research Case Studies
    Figure 11. Clinical Case Studies
    Figure 12. Commercial Case Studies
    Figure 13. Liposomal Formulation Development Service Report Years Considered
    Figure 14. Global Liposomal Formulation Development Service Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Liposomal Formulation Development Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Liposomal Formulation Development Service Market Share by Region: 2023 VS 2030
    Figure 17. Global Liposomal Formulation Development Service Market Share by Players in 2023
    Figure 18. Global Top Liposomal Formulation Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liposomal Formulation Development Service as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Liposomal Formulation Development Service Revenue in 2023
    Figure 20. North America Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Liposomal Formulation Development Service Market Share by Type (2019-2030)
    Figure 22. North America Liposomal Formulation Development Service Market Share by Application (2019-2030)
    Figure 23. North America Liposomal Formulation Development Service Market Share by Country (2019-2030)
    Figure 24. United States Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Liposomal Formulation Development Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Liposomal Formulation Development Service Market Share by Type (2019-2030)
    Figure 28. Europe Liposomal Formulation Development Service Market Share by Application (2019-2030)
    Figure 29. Europe Liposomal Formulation Development Service Market Share by Country (2019-2030)
    Figure 30. Germany Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Liposomal Formulation Development Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Liposomal Formulation Development Service Market Share by Type (2019-2030)
    Figure 38. China Liposomal Formulation Development Service Market Share by Application (2019-2030)
    Figure 39. Asia Liposomal Formulation Development Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Liposomal Formulation Development Service Market Share by Type (2019-2030)
    Figure 41. Asia Liposomal Formulation Development Service Market Share by Application (2019-2030)
    Figure 42. Asia Liposomal Formulation Development Service Market Share by Region (2019-2030)
    Figure 43. Japan Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Liposomal Formulation Development Service Market Share by Country (2019-2030)
    Figure 53. Brazil Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Liposomal Formulation Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Creative Biolabs Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 60. LipExoGen Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 61. Project Pharmaceutics Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 62. Polymun Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 63. Exelead Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 64. CD Formulation Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 65. Anglo Bio-Pharma Limited Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 66. Liposoma BV Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 67. Dalton Pharma Services Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 68. Creative Biostructure Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 69. BOC Sciences Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 70. Encapsula NanoSciences LLC Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 71. Fujifilm Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 72. CD Bioparticles Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 73. Precision NanoSystems Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 74. Evonik Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 75. Genevant Sciences Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 76. Avanti Polar Lipids Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 77. Nippon Fine Chemical Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 78. Lipoid Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 79. Corden Pharma Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 80. Acuitas Therapeutics Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 81. T&T Scientific Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 82. FormuMax Scientific Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 83. PlantaCorp Revenue Growth Rate in Liposomal Formulation Development Service Business (2019-2024)
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed

Related Reports

• 

  Liposomal Formulation Development Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  The global market for Liposomal Formulation Development Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

  

  Published: 2024-01-05

  

  Pages: 163

  USD 3950.00

  (Single User License)

• 

  Global Liposomal Formulation Development Service Market Research Report 2024

  The global Liposomal Formulation Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

  

  Published: 2024-01-21

  

  Pages: 101

  USD 2900.00

  (Single User License)

• 

  Global Liposomal Formulation Development Service Market Research Report 2025

  The global market for Liposomal Formulation Development Service was valued at US$ 501 million in the year 2024 and is projected to reach a revised size of US$ 1220 million by 2031, growing at a CAGR of 12.3% during the forecast period.

  

  Published: 2025-08-05

  

  Pages: 100

  USD 2900.00

  (Single User License)

• 

  Liposomal Formulation Development Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  The global market for Liposomal Formulation Development Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

  

  Published: 2025-03-03

  

  Pages: 142

  USD 3950.00

  (Single User License)

• 

  Global Liposomal Formulation Development Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  The global Liposomal Formulation Development Service market size was US$ 501 million in 2024 and is forecast to a readjusted size of US$ 1220 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.

  

  Published: 2025-09-06

  

  Pages: 106

  USD 4250.00

  (Single User License)

• 

  Liposomal Formulation Development Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  The global market for Liposomal Formulation Development Service was estimated to be worth US$ 501 million in 2024 and is forecast to a readjusted size of US$ 1220 million by 2031 with a CAGR of 12.3% during the forecast period 2025-2031.

  

  Published: 2025-08-05

  

  Pages: 134

  USD 3950.00

  (Single User License)

• 

  Global Liposomal Formulation Development Service Market Outlook, In‑Depth Analysis & Forecast to 2031

  The global Liposomal Formulation Development Service market is projected to grow from US$ 501 million in 2024 to US$ 1220 million by 2031, at a CAGR of 12.3% (2025-2031), driven by critical product segments and diverse end‑use applications.

  

  Published: 2025-10-03

  

  Pages: 153

  USD 4900.00

  (Single User License)

• 

  Global Liposomal Formulation Development Service Market Research Report 2026

  The global Liposomal Formulation Development Service market was valued at US$ 608 million in 2025 and is anticipated to reach US$ 1354 million by 2032, at a CAGR of 12.3% from 2026 to 2032.

  

  Published: 2026-02-11

  

  Pages: 138

  USD 2900.00

  (Single User License)

• 

  Liposomal Formulation Development Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

  The global market for Liposomal Formulation Development Service was estimated to be worth US$ 608 million in 2025 and is projected to reach US$ 1354 million, growing at a CAGR of 12.3% from 2026 to 2032.

  

  Published: 2026-02-11

  

  Pages: 138

  USD 3950.00

  (Single User License)